Searched for
ANTIVIRAL MEDICINES
These large- and mid-cap stocks can give more than 20% return in 1 year, according to analystsIn just a few days, the Q1 earnings season for FY27 will start. But before that will come the season of business updates. And that needs to...- These large-, mid- and small-cap stocks can give more than 25% return in 1 year, according to analystsAs the old saying goes: Nothing can be ruled out on the street. Which means that one should be prepared for anything. Now, what is the prob...
- These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 27%As the market seems to be in comeback mode, it helps to be aware that the best (and probably biggest) wealth creator of the last couple of ...
- These large- and mid-cap stocks can give more than 25% return in 1 year, according to analystsThere are market phases when one risk dominates. Then there are phases like this, when risks arrive from every direction and refuse to stan...
- Over 1,500 bat species carry thousands of deadly viruses but rarely get sick, and scientists are only just beginning to understand whyBats possess a unique, preactivated innate immune defense that stops viruses from fully replicating, even after cell entry. This remarkable...
- These large- and mid-cap stocks may give more than 25% return in 1 year, according to analystsFor the last few earnings seasons, the message has been: “Show me growth, I have the money.” Stocks with better-than-expected earnings saw ...
- Trump will send Americans exposed to Ebola while abroad to a new facility in KenyaAmerica's Trump administration is planning a new Ebola treatment center in Kenya. This facility will care for Americans exposed to the viru...
- Long-term Investing: Ecosystem with an edge called India; 12 large- mid- and small-cap stocks with upside potential of up to 34%Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...
- That dusty cabin you're opening this weekend could be hiding a deadly virusSpring cleaning at cabins can be dangerous. Hantavirus, carried by mice, spreads through droppings and urine. Inhaling dust from these can ...
- Hantavirus in India? Health Ministry activates precautionary surveillance measures; check what is Andes virus, signs, symptoms and prevention tipsHantavirus update: India has heightened surveillance for Hantavirus following an outbreak on the cruise ship MV Hondius, which reported eig...
- Rare but ruthless: How Hantavirus strikes fast, and should you be concernedA rare hantavirus outbreak linked to a cruise ship has drawn global attention after multiple infections and three reported deaths prompted ...
- Hetero's oral drug gets WHO PrequalificationIt is the first prequalification for a generic version of Pfizer's Covid-19 oral antiviral drug paxlovid, the company said. The WHO made a ...
- Lupin launches Molnulup for COVID-19 treatmentMolnupiravir has been given emergency use authorisation by the Drug Controller General of India (DCGI) for treatment of adult COVID-19 pati...
- Merck v Pfizer: here's how the two new COVID antiviral drugs work and will be usedUK approved molnupiravir, the COVID antiviral developed by Merck and Ridgeback Therapeutics. Now, Pfizer has released results from trials o...
- Local firms gear up to seek licence for Pfizer's Covid drugUS drug giant Pfizer on Tuesday announced a deal with MPP - a UN-backed public health organization - to issue royalty-free voluntary licenc...
- Indian pharma eyes affordable antiviral medicines to treat Covid-19The coronavirus is headed to the endemic stage in certain countries, giving these new drugs a potentially huge market, along with the abili...
- Pfizer enters deal with UN-backed MPP to license COVID drug in 95 countries including IndiaPfizer said it will waive royalties on sales in all countries covered by the agreement while COVID-19 remains classified as a Public Health...
- MSD enters pact with UN-backed MPP to license COVID drug molnupiravir in 105 countries including IndiaUnder the terms of the agreement, MPP will be permitted to further license non-exclusive sub-licences to manufacturers and diversify the ma...
- Gilead’s remdesivir mainly helped healthier Covid-19 patientsThe publication also allowed greater insight into which patients seemed to respond best to treatment. The only group to do significantly be...
- Swine flu kills over 600 people in India, worries health ministry and doctorsThe ministry's directed pharma companies to expedite supply of antiviral medicines to state hospitals and licensed retail outlets.
Load More
